Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

The NHS has announced that the drug, abiraterone, will be offered to men with high-risk prostate cancer that has not yet ...

The NHS has announced that the drug, abiraterone, will be offered to men with high-risk prostate cancer that has not yet ...

The ACS estimates that 626,140 people in the U.S. will die from cancer in 2026, amounting to about 1,720 deaths per day. Lung ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

NHS England has expanded access to the prostate cancer drug abiraterone after patient and charity campaigning. Previously ...

Willy Goldschmidt is among a group of patients from University Hospitals Coventry and Warwickshire NHS Trust who have taken ...

In May 2025, Joe Biden's office announced that he had been diagnosed with an aggressive form of prostate cancer that had ...

Oncoscope launches the first Real-time, AI-supported Living Systematic Literature Review designed for enterprise-wide ...

A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...